MI MEDICAL INNOVATION GMBH

MI is engaged in medical device probe and implant developments, Hyper-IMS patents at MI, regulatory under umbrella of CGS sensors. It has been awarded a Horizon 2020 SME Instrument phase 1 grant from the European Commission to develop Sniff-Nose for clinical assessment of heart failure. MI is a concept company to give a platform to new ideas under constraints of correct medical device regulatory. The joint project proposed together with our French partner, emka TECHNOLOGIES, got granted with Horizon 2020 Seal of Excellence, issued by the European Commission on 8 February 2016.